SABCS 2015: Denosumab Improves Outcomes for Patients Taking Aromatase Inhibitors
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...